BBH

Vaneck Biotech ETF

-$648.9K

Net Activity

Institutions Holding

111

Popularity Rank

#4234

Avg Weight

0.08%

Total Value

$126.4M

Ownership Trend

111 institutions currently hold BBH, with 35 net buyers and 38 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

38

Net Buying Institutions

35

Key Holders

View all 111 holding institutions

Quarterly Activity

Recent Activity

+$59.9M

Total Buy Value

$58.5M

Total Sell Value

New buy14
Trim25
Add21
Sold out13

35

Net Buyers

38

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding VANECK BIOTECH ETF (BBH)?
Major stakeholders currently include Goldman Sachs Group INC ($19.2M), Raymond James Financial INC ($13.1M), Bank Of America CORP /de/ ($12.5M). Based on the latest 13F filings, there are a total of 111 tracked investment funds and institutions maintaining positions in BBH.
What is the overall institutional sentiment toward BBH recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $648.9K, driven by 35 managers accumulating shares while 38 reduced their exposure.
Which institutions have been selling or reducing their BBH positions?
In the latest period, 25 funds trimmed their holdings, and 13 managers completely exited their positions. The aggregate reported sell value was $58.5M.
Are there any notable investors adding BBH to their portfolios?
Yes, buying activity remains notable. 14 institutions opened new positions in {ticker}, and 21 existing holders added to their shares. The total reported buy value for the quarter amounted to $59.9M.

Related Stocks